Peak6 Investments LLC Blueprint Medicines Corp Call Options Transaction History

Peak6 Investments LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 13, 2024	BUY	$85.18 - $108.78 $85,180 - $108,780	1,000 Added 6.13%	17,300 $1.86 Million
Q1 2024 May 14, 2024	BUY	$73.17 - $99.79 $936,576 - $1.28 Million	12,800 Added 365.71%	16,300 $1.55 Million
Q4 2023 Feb 13, 2024	SELL	$43.96 - $92.84 $1.49 Million - $3.16 Million	-34,000 Reduced 90.67%	3,500 $322,000
Q3 2023 Nov 13, 2023	BUY	$46.9 - $66.0 $520,590 - $732,600	11,100 Added 42.05%	37,500 $1.88 Million
Q2 2023 Aug 11, 2023	BUY	$42.2 - $66.37 $1.11 Million - $1.75 Million	26,400 New	26,400 $1.67 Million

352

60.3M

2.25M

1.18M

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.7B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.